133 related articles for article (PubMed ID: 30747549)
41. Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolites.
Tang W; Stearns RA; Bandiera SM; Zhang Y; Raab C; Braun MP; Dean DC; Pang J; Leung KH; Doss GA; Strauss JR; Kwei GY; Rushmore TH; Chiu SH; Baillie TA
Drug Metab Dispos; 1999 Mar; 27(3):365-72. PubMed ID: 10064567
[TBL] [Abstract][Full Text] [Related]
42. One-electron oxidation of diclofenac by human cytochrome P450s as a potential bioactivation mechanism for formation of 2'-(glutathion-S-yl)-deschloro-diclofenac.
Boerma JS; Vermeulen NP; Commandeur JN
Chem Biol Interact; 2014 Jan; 207():32-40. PubMed ID: 24246759
[TBL] [Abstract][Full Text] [Related]
43. Species-specific Bioactivation of Morpholines as a Causative of Drug Induced Liver Injury Observed in Monkeys.
Gunduz M; Argikar UA; Cirello AL; Brown AP; Bonazzi S; Walles M
Drug Metab Bioanal Lett; 2023 Dec; ():. PubMed ID: 38047363
[TBL] [Abstract][Full Text] [Related]
44. Reaction of glutathione with the electrophilic metabolites of 1,1-dichloroethylene.
Dowsley TF; Forkert PG; Benesch LA; Bolton JL
Chem Biol Interact; 1995 Apr; 95(3):227-44. PubMed ID: 7728894
[TBL] [Abstract][Full Text] [Related]
45. In Vitro Metabolism of Slowly Cleared G Protein-Coupled Receptor 139 Agonist TAK-041 Using Rat, Dog, Monkey, and Human Hepatocyte Models (HepatoPac): Correlation with In Vivo Metabolism.
Kamel A; Bowlin S; Hosea N; Arkilo D; Laurenza A
Drug Metab Dispos; 2021 Feb; 49(2):121-132. PubMed ID: 33273044
[TBL] [Abstract][Full Text] [Related]
46. In vitro metabolism of N-(5-chloro-2-methylphenyl)-N'-(2-methylpropyl)thiourea: species comparison and identification of a novel thiocarbamide-glutathione adduct.
Stevens GJ; Hitchcock K; Wang YK; Coppola GM; Versace RW; Chin JA; Shapiro M; Suwanrumpha S; Mangold BL
Chem Res Toxicol; 1997 Jul; 10(7):733-41. PubMed ID: 9250406
[TBL] [Abstract][Full Text] [Related]
47. In vitro metabolism of oxymetazoline: evidence for bioactivation to a reactive metabolite.
Mahajan MK; Uttamsingh V; Daniels JS; Gan LS; LeDuc BW; Williams DA
Drug Metab Dispos; 2011 Apr; 39(4):693-702. PubMed ID: 21177487
[TBL] [Abstract][Full Text] [Related]
48. Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.
Kassahun K; Pearson PG; Tang W; McIntosh I; Leung K; Elmore C; Dean D; Wang R; Doss G; Baillie TA
Chem Res Toxicol; 2001 Jan; 14(1):62-70. PubMed ID: 11170509
[TBL] [Abstract][Full Text] [Related]
49. In vitro Drug Metabolism Investigation of 7-Ethoxycoumarin in Human, Monkey, Dog and Rat Hepatocytes by High Resolution LC-MS/MS.
Feng WY; Wen J; Stauber K
Drug Metab Lett; 2018; 12(1):33-53. PubMed ID: 29669508
[TBL] [Abstract][Full Text] [Related]
50. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
Lang D; Freudenberger C; Weinz C
Drug Metab Dispos; 2009 May; 37(5):1046-55. PubMed ID: 19196846
[TBL] [Abstract][Full Text] [Related]
51. Characterization of the in vitro metabolites of idelalisib in liver microsomes and interspecies comparison.
Chen CM; Wu WB; Chen JF; Chen Y
J Pharm Biomed Anal; 2019 Jan; 162():249-256. PubMed ID: 30268993
[TBL] [Abstract][Full Text] [Related]
52. In vitro metabolism of [
Nallani GC; ElNaggar SF; Shen L; Chandrasekaran A
Regul Toxicol Pharmacol; 2017 Mar; 84():26-34. PubMed ID: 27993653
[TBL] [Abstract][Full Text] [Related]
53. Bioactivation of phencyclidine in rat and human liver microsomes and recombinant P450 2B enzymes: evidence for the formation of a novel quinone methide intermediate.
Driscoll JP; Kornecki K; Wolkowski JP; Chupak L; Kalgutkar AS; O'Donnell JP
Chem Res Toxicol; 2007 Oct; 20(10):1488-97. PubMed ID: 17892269
[TBL] [Abstract][Full Text] [Related]
54. Characterization of the metabolites of gigantol in rat, dog, monkey, and human hepatocytes using ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry.
Wang J; Liu Y; Liu C; Shi Q
Rapid Commun Mass Spectrom; 2020 Jul; 34(13):e8810. PubMed ID: 32267985
[TBL] [Abstract][Full Text] [Related]
55. Bioactivation of benzylamine to reactive intermediates in rodents: formation of glutathione, glutamate, and peptide conjugates.
Mutlib AE; Dickenson P; Chen SY; Espina RJ; Daniels JS; Gan LS
Chem Res Toxicol; 2002 Sep; 15(9):1190-207. PubMed ID: 12230413
[TBL] [Abstract][Full Text] [Related]
56. In vitro metabolic activation of triphenyl phosphate leading to the formation of glutathione conjugates by rat liver microsomes.
Chu S; Letcher RJ
Chemosphere; 2019 Dec; 237():124474. PubMed ID: 31377596
[TBL] [Abstract][Full Text] [Related]
57. Effect of human glutathione S-transferases on glutathione-dependent inactivation of cytochrome P450-dependent reactive intermediates of diclofenac.
Dragovic S; Boerma JS; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2013 Nov; 26(11):1632-41. PubMed ID: 24083800
[TBL] [Abstract][Full Text] [Related]
58. Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells.
Reilly CA; Ehlhardt WJ; Jackson DA; Kulanthaivel P; Mutlib AE; Espina RJ; Moody DE; Crouch DJ; Yost GS
Chem Res Toxicol; 2003 Mar; 16(3):336-49. PubMed ID: 12641434
[TBL] [Abstract][Full Text] [Related]
59. In vitro metabolism of tolcapone to reactive intermediates: relevance to tolcapone liver toxicity.
Smith KS; Smith PL; Heady TN; Trugman JM; Harman WD; Macdonald TL
Chem Res Toxicol; 2003 Feb; 16(2):123-8. PubMed ID: 12588182
[TBL] [Abstract][Full Text] [Related]
60. Role of human glutathione S-transferases in the inactivation of reactive metabolites of clozapine.
Dragovic S; Boerma JS; van Bergen L; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2010 Sep; 23(9):1467-76. PubMed ID: 20849150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
